OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial
Shubham Pant, Zev A. Wainberg, Colin D. Weekes, et al.
Nature Medicine (2024) Vol. 30, Iss. 2, pp. 531-542
Open Access | Times Cited: 74

Showing 1-25 of 74 citing articles:

Targeting KRAS in cancer
Anupriya Singhal, Bob T. Li, Eileen M. O’Reilly
Nature Medicine (2024) Vol. 30, Iss. 4, pp. 969-983
Closed Access | Times Cited: 67

Current and future immunotherapeutic approaches in pancreatic cancer treatment
Pooya Farhangnia, Hossein Khorramdelazad, Hamid Nickho, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 29

RNA vaccines for cancer: Principles to practice
Pablo Guasp, Charlotte Reiche, Zachary Sethna, et al.
Cancer Cell (2024) Vol. 42, Iss. 7, pp. 1163-1184
Closed Access | Times Cited: 14

Consensus, debate, and prospective on pancreatic cancer treatments
Junke Wang, Jie Yang, Amol Narang, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 11

The therapeutic potential of immunoengineering for systemic autoimmunity
David A. McBride, Ryan M. Jones, Nunzio Bottini, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 4, pp. 203-215
Closed Access | Times Cited: 9

State-Of-The-Art Advancements on Cancer Vaccines and Biomarkers
Scott Strum, Mads Hald Andersen, Inge Marie Svane, et al.
American Society of Clinical Oncology Educational Book (2024) Vol. 44, Iss. 3
Closed Access | Times Cited: 8

Architects of immunity: How dendritic cells shape CD8 + T cell fate in cancer
Vidit Bhandarkar, Teresa Dinter, Stefani Spranger
Science Immunology (2025) Vol. 10, Iss. 103
Closed Access | Times Cited: 1

Cancer vaccines: current status and future directions
Yi Zhou, Yuquan Wei, Xiaohe Tian, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 1

Dendritic Cell–Based Immunotherapy in Patients With Resected Pancreatic Cancer
Freek R. van ‘t Land, Marcella Willemsen, Koen Bezemer, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 26, pp. 3083-3093
Open Access | Times Cited: 6

Development of an engineered extracellular vesicles-based vaccine platform for combined delivery of mRNA and protein to induce functional immunity
Xin Luo, Kathleen M. McAndrews, Kent A. Arian, et al.
Journal of Controlled Release (2024) Vol. 374, pp. 550-562
Open Access | Times Cited: 6

Cancer vaccines: Target antigens, vaccine platforms and preclinical models
Francesca Ruzzi, Federica Riccardo, Laura Conti, et al.
Molecular Aspects of Medicine (2024) Vol. 101, pp. 101324-101324
Open Access | Times Cited: 4

Advances in Novel Targeted Therapies for Pancreatic Adenocarcinoma
Tuan Hoang, Erica S. Tsang
Journal of Gastrointestinal Cancer (2025) Vol. 56, Iss. 1
Closed Access

The Landmark Series: The Future of Pancreatic Cancer Clinical Trials
Yongwoo David Seo, Matthew H. G. Katz, Rebecca A. Snyder
Annals of Surgical Oncology (2025) Vol. 32, Iss. 4, pp. 2777-2785
Closed Access

The enhancing effect of DNA tetrahedron-based lactoferrin as an assembled adjuvant in immunotherapy
Miaomiao Xu, Tian‐Hua Zhou, Bowen Yang, et al.
Chemical Engineering Journal (2025) Vol. 506, pp. 159941-159941
Closed Access

Cancer Vaccines and Beyond: The Transformative Role of Nanotechnology in Immunotherapy
Violeta Delgado-Almenta, José L. Blaya-Cánovas, Jesús Calahorra, et al.
Pharmaceutics (2025) Vol. 17, Iss. 2, pp. 216-216
Open Access

Advances in Vaccine-Based Therapies for Pancreatic Cancer
Matthew T. McMillan, Kevin C. Soares
Journal of Gastrointestinal Cancer (2025) Vol. 56, Iss. 1
Open Access

Linking vaccine adjuvant mechanisms of action to function
Elana Ben‐Akiva, Asheley P. Chapman, Tianyang Mao, et al.
Science Immunology (2025) Vol. 10, Iss. 104
Closed Access

KRAS Mutations in Cancer: Understanding Signaling Pathways to Immune Regulation and the Potential of Immunotherapy
Priyanka Uniyal, Vivek K. Kashyap, Tapan Behl, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 785-785
Open Access

Treatment Innovations in Pancreatic Cancer: Putting Patient Priorities First
Kim A. Reiss, Kevin C. Soares, Robert J. Torphy, et al.
American Society of Clinical Oncology Educational Book (2025) Vol. 45, Iss. 3
Closed Access

Pancreatic Cancer: Pathogenesis and Clinical Studies
Kexun Zhou, Yingping Liu, Chuanyun Tang, et al.
MedComm (2025) Vol. 6, Iss. 4
Open Access

Immune-Based Strategies for Pancreatic Cancer in the Adjuvant Setting
Kaili Liang, Nilofer S. Azad
Cancers (2025) Vol. 17, Iss. 7, pp. 1246-1246
Open Access

Administration route-commended concise organ-selective mRNA transfection (ACCOST) by cyclic disulfide-primed short polyethylenimine
Ruonan Ye, Qiang Ren, Limin Chang, et al.
Nano Today (2025) Vol. 63, pp. 102741-102741
Closed Access

Page 1 - Next Page

Scroll to top